Pulmonx Corporation (LUNG)

NASDAQ: LUNG · Real-Time Price · USD

3.77

-1.06 (-21.95%)

At close: May 01, 2025, 3:59 PM

3.78

0.40%

Pre-market: May 02, 2025, 07:00 AM EDT

Pulmonx Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-56.39M	-60.84M	-58.92M	-48.66M	-32.23M	-20.7M	-18.48M
Depreciation & Amortization	1.49M	1.55M	1.51M	867K	483K	365K	270K
Stock-Based Compensation	22.95M	22.1M	16.45M	10.53M	3.2M	364K	366K
Other Working Capital	n/a	-27K	-1.43M	957K	-1.79M	2.21M	632K
Other Non-Cash Items	409K	2.14M	2.85M	2.47M	5.46M	864K	36K
Deferred Income Tax	n/a	n/a	49K	1.26M	-2.76M	746K	936K
Change in Working Capital	n/a	-2.56M	-7.01M	-7.85M	-4.79M	-2.4M	-1.52M
Operating Cash Flow	-31.54M	-37.61M	-45.08M	-41.39M	-30.63M	-20.77M	-18.39M
Capital Expenditures	-1.45M	-807K	-1.32M	-3.67M	-911K	-720K	-316K
Cash Acquisitions	n/a	n/a	2.91M	42.58M	n/a	13.51M	16K
Purchase of Investments	-27.91M	-46.2M	-47.19M	-52.58M	n/a	-21.45M	n/a
Sales Maturities Of Investments	46.84M	45M	44.28M	10M	13.61M	7.94M	500K
Other Investing Acitivies	n/a	n/a	-2.91M	-42.58M	13.61M	-13.51M	16K
Investing Cash Flow	17.48M	-2.01M	-4.22M	-46.26M	12.69M	-14.23M	200K
Debt Repayment	-95K	19.91M	-87K	n/a	32.99M	6M	12M
Common Stock Repurchased	1.24M	1.18M	-27K	-26K	n/a	-12K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.46M	1.49M	2.51M	4.46M	446K	-52K	114K
Financial Cash Flow	1.36M	21.4M	2.47M	4.46M	234.83M	45.62M	12.11M
Net Cash Flow	-12.62M	-18.18M	-46.74M	-83.08M	217.03M	10.64M	-5.93M
Free Cash Flow	-32.98M	-38.42M	-46.4M	-45.06M	-31.54M	-21.48M	-18.71M